Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint TherapyKathrin Renner, Marina Kreutz, Ayse N. Menevse et al.|Cell Reports|2019Cited by 297
Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 SecretionChristina Bruß, Anja K. Wege|Cancers|2023Cited by 19
Neoadjuvant radiotherapy in ER+, HER2+, and triple-negative -specific breast cancer based humanized tumor mice enhances anti-PD-L1 treatment efficacyChristina Bruß, Anja K. Wege|Frontiers in Immunology|2024Cited by 7